Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
- PMID: 19323780
- PMCID: PMC2711255
- DOI: 10.1111/j.1478-3231.2008.01920.x
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
Abstract
Objective: The association of nonalcoholic fatty liver disease (NAFLD) with insulin resistance and metabolic syndrome has been documented for obese men and middle-aged men. This study was designed to determine the relationship between NAFLD and the oral glucose tolerance test (OGTT) to predict preclinical diabetes in nondiabetic young male patients (<30 years old).
Methods: A total of 75 male patients who had elevated liver enzymes and who were diagnosed with NAFLD were enrolled in this study. A standard 75 g OGTT was carried out on all patients. Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) were defined as a fasting plasma glucose (FPG) level > or =100 mg/dl but <126 mg/dl, and a 2-h post-load glucose on the OGTT of > or =140 mg/dl, but <200 mg/dl respectively.
Results: According to the OGTT results, 24 (32%) patients were diagnosed as having IGT and 12 (16%) patients were diagnosed as having diabetes. Among the 48 patients with normal fasting glucose, 18 (37.6%) patients showed abnormal glucose tolerance (15 had IGT and three had diabetes). The NAFLD patients with abnormal glucose tolerance showed significant differences in age, weight, body mass index, waist-hip ratio, alanine aminotransferase, total bilirubin, total cholesterol, low-density lipoprotein cholesterol, triglyceride, insulin, FPG and homeostasis model for insulin resistance (HOMA-IR). Multiple regression analysis showed that age, FPG and HOMA-IR were independent predictors of abnormal glucose tolerance.
Conclusions: Although the patients were young men, an OGTT should be recommended for NAFLD patients with elevated liver enzymes and IFG to predict the risk of type 2 diabetes.
Figures

Similar articles
-
Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402. doi: 10.1097/00004836-200311000-00010. J Clin Gastroenterol. 2003. PMID: 14564188
-
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28. J Clin Endocrinol Metab. 2013. PMID: 23539736 Clinical Trial.
-
Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan.Intern Med. 2015;54(8):875-80. doi: 10.2169/internalmedicine.54.3437. Epub 2015 Apr 15. Intern Med. 2015. PMID: 25876566
-
Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.J Clin Endocrinol Metab. 2012 Dec;97(12):4717-23. doi: 10.1210/jc.2012-2414. Epub 2012 Oct 12. J Clin Endocrinol Metab. 2012. PMID: 23066121
-
From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research.Medicina (Kaunas). 2019 Aug 29;55(9):546. doi: 10.3390/medicina55090546. Medicina (Kaunas). 2019. PMID: 31470636 Free PMC article. Review.
Cited by
-
Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study.PLoS One. 2011;6(8):e22932. doi: 10.1371/journal.pone.0022932. Epub 2011 Aug 5. PLoS One. 2011. PMID: 21850244 Free PMC article.
-
Prediabetes and associated disorders.Endocrine. 2015 Mar;48(2):371-93. doi: 10.1007/s12020-014-0436-2. Epub 2014 Oct 8. Endocrine. 2015. PMID: 25294012 Review.
-
Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes.J Clin Med. 2021 Apr 15;10(8):1695. doi: 10.3390/jcm10081695. J Clin Med. 2021. PMID: 33920792 Free PMC article.
-
Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease.Exp Diabetes Res. 2012;2012:351974. doi: 10.1155/2012/351974. Epub 2011 Sep 21. Exp Diabetes Res. 2012. PMID: 21960993 Free PMC article.
-
One-Hour Postload Plasma Glucose in Obese Indian Adults with Nonalcoholic Fatty Liver Disease: An Observational Study from North India.Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):450-455. doi: 10.4103/ijem.ijem_357_21. Epub 2022 Jan 12. Indian J Endocrinol Metab. 2021. PMID: 35300452 Free PMC article.
References
-
- Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7. - PubMed
-
- Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–95. - PubMed
-
- Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40:S5–10. - PubMed
-
- Leite NC SG, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009;29:113–19. - PubMed
-
- Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21:138–43. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical